IL214257A - Preparation containing polypeptides for use in preventing and treating allergy to herbal dust by tolerating - Google Patents
Preparation containing polypeptides for use in preventing and treating allergy to herbal dust by toleratingInfo
- Publication number
- IL214257A IL214257A IL214257A IL21425711A IL214257A IL 214257 A IL214257 A IL 214257A IL 214257 A IL214257 A IL 214257A IL 21425711 A IL21425711 A IL 21425711A IL 214257 A IL214257 A IL 214257A
- Authority
- IL
- Israel
- Prior art keywords
- tolerisation
- polypeptides
- preventing
- composition
- grass pollen
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 208000026935 allergic disease Diseases 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 229940046528 grass pollen Drugs 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
- G01N33/56977—HLA or MHC typing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Tropical Medicine & Parasitology (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0901927.4A GB0901927D0 (en) | 2009-02-05 | 2009-02-05 | Peptide for IL10 production |
| GB0901928A GB0901928D0 (en) | 2009-02-05 | 2009-02-05 | Peptides for vaccine |
| GB0912578A GB0912578D0 (en) | 2009-07-20 | 2009-07-20 | Peptide for IL-10 production |
| PCT/GB2009/001995 WO2010018384A1 (en) | 2008-08-15 | 2009-08-14 | T-cell antigen peptide from allergen for stimulation of il-10 production |
| GB0917871A GB0917871D0 (en) | 2009-10-12 | 2009-10-12 | Peptides for vaccine |
| PCT/GB2010/000198 WO2010089554A1 (en) | 2009-02-05 | 2010-02-05 | Peptides for vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL214257A0 IL214257A0 (en) | 2011-09-27 |
| IL214257A true IL214257A (en) | 2016-06-30 |
Family
ID=42082585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL214257A IL214257A (en) | 2009-02-05 | 2011-07-24 | Preparation containing polypeptides for use in preventing and treating allergy to herbal dust by tolerating |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8753644B2 (enExample) |
| EP (2) | EP2393830B8 (enExample) |
| JP (2) | JP5746053B2 (enExample) |
| KR (1) | KR20110111307A (enExample) |
| CN (2) | CN102307893B (enExample) |
| AU (1) | AU2010212193B2 (enExample) |
| BR (1) | BRPI1008802A2 (enExample) |
| CA (1) | CA2751500A1 (enExample) |
| DK (1) | DK2393830T3 (enExample) |
| EA (1) | EA020792B1 (enExample) |
| ES (1) | ES2532759T3 (enExample) |
| GB (1) | GB2469894B (enExample) |
| HK (1) | HK1212358A1 (enExample) |
| HR (1) | HRP20150317T1 (enExample) |
| IL (1) | IL214257A (enExample) |
| MX (1) | MX2011008179A (enExample) |
| NZ (1) | NZ594268A (enExample) |
| PL (1) | PL2393830T3 (enExample) |
| PT (1) | PT2393830E (enExample) |
| SG (1) | SG173523A1 (enExample) |
| SI (1) | SI2393830T1 (enExample) |
| WO (1) | WO2010089554A1 (enExample) |
| ZA (1) | ZA201105436B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2393830T1 (sl) * | 2009-02-05 | 2015-04-30 | Circassia Limited | Travni peptidi za cepivo |
| CN107320734A (zh) * | 2011-04-29 | 2017-11-07 | 西莱克塔生物科技公司 | 从合成纳米载体中控制释放免疫抑制剂 |
| CN105307641A (zh) | 2013-05-03 | 2016-02-03 | 西莱克塔生物科技公司 | 用于降低不期望体液免疫应答的给药组合 |
| EA201790551A1 (ru) | 2014-09-07 | 2017-07-31 | Селекта Байосайенсиз, Инк. | Способы и композиции для ослабления иммунных ответов к пропускающему экзон вирусному трансферному вектору |
| WO2017004561A1 (en) | 2015-07-01 | 2017-01-05 | Alk-Abelló A/S | Peptide combinations and uses thereof for treating grass allergy |
| EP4599848A3 (en) | 2017-03-11 | 2025-12-03 | Cartesian Therapeutics, Inc. | Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant |
| EP3672600A4 (en) | 2017-08-21 | 2021-05-19 | Glycom A/S | SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS |
| CN108802216B (zh) * | 2018-05-23 | 2021-04-16 | 山东出入境检验检疫局检验检疫技术中心 | 一种使用区域敏感性蛋白组和/或多肽组鉴别刺参产地的方法 |
| US12553041B2 (en) | 2019-06-04 | 2026-02-17 | Cartesian Therapeutics Inc. | Formulations and doses of pegylated uricase |
Family Cites Families (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1340729C (en) | 1988-03-23 | 1999-09-07 | Mohan Bir Singh | Ryegrass pollen allergen |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
| CA2089735C (en) | 1990-08-17 | 2008-03-18 | Mohan Bir Singh | Ryegrass pollen allergen |
| WO1992016554A1 (en) | 1991-03-14 | 1992-10-01 | The University Of Melbourne | Protein allergens of the species cynodon dactylon |
| WO1994001560A1 (en) | 1991-07-12 | 1994-01-20 | Immulogic Pharmaceutical Corporation | Allergenic proteins and peptides from japanese cedar pollen |
| EP0665888B2 (en) | 1991-08-16 | 2007-07-25 | The University Of Melbourne | Ryegrass pollen allergen |
| EP0668915A1 (en) | 1991-11-15 | 1995-08-30 | The University Of Melbourne | Protein allergens of the species cynodon dactylon |
| US6441157B1 (en) | 1991-11-15 | 2002-08-27 | University Of Melbourne | Nucleic acid sequences encoding protein allergens of the species Cynodon dactylon |
| ATE283281T1 (de) | 1992-08-14 | 2004-12-15 | Univ Melbourne | T-zell epitope des raygraspollen-allergens |
| US5480972A (en) | 1992-10-30 | 1996-01-02 | The University Of Melbourne | Allergenic proteins from Johnson grass pollen |
| US6214358B1 (en) | 1992-10-30 | 2001-04-10 | Immulogic Pharamaceutical Corp. | Protein allergens of the species Cynodon dactylon |
| NZ263913A (en) * | 1993-03-12 | 1997-10-24 | Immulogic Pharma Corp | Lol pi protein allergen from ryegrass and related peptides coding sequences, vectors, protein production and use |
| FI960629L (fi) * | 1993-08-13 | 1996-04-12 | Immulogic Pharma Corp | Raiheinäsiitepöly allergeenin T-soluepitoopit |
| US5968526A (en) | 1994-04-14 | 1999-10-19 | Immulogic Pharamaceutical Corporation | T cell epitopes of the major allergens from Dermatophagoides (house dust mite) |
| GB9412714D0 (en) | 1994-06-24 | 1994-08-17 | Lewin Ian V | T cill epitopes |
| AU3338195A (en) * | 1994-07-26 | 1996-02-22 | University Of Manitoba | Allergen peptides |
| US7112333B1 (en) | 1994-08-05 | 2006-09-26 | Heska Corporation | T cell epitopes of ryegrass pollen allergen |
| IL115744A (en) | 1994-10-27 | 2000-07-16 | Akzo Nobel Nv | Peptides comprising a subsequence of human cartilage glycoprotein - 39 |
| AT402505B (de) | 1995-08-02 | 1997-06-25 | Biomay Prod & Handel | Rekombinantes 60 kda pflanzliches panallergen (kofaktor-unabhängige phosphoglyceratmutase; e.c. 5.4.2.1.) |
| JP2002500198A (ja) | 1998-01-09 | 2002-01-08 | サーカシア リミテッド | 脱感作のための方法及び組成物 |
| DE19823097A1 (de) * | 1998-05-22 | 1999-11-25 | Max Planck Gesellschaft | Mittel gegen saisonale Typ-I-Allergien und bakterielle Infektionen |
| US6989146B2 (en) | 2000-08-09 | 2006-01-24 | The Regents Of The University Of California | Stress proteins and peptides and methods of use thereof |
| AUPR775401A0 (en) * | 2001-09-18 | 2001-10-11 | Monash University | Novel Epitopes and Uses Thereof |
| WO2003047618A2 (en) | 2001-12-05 | 2003-06-12 | Circassia Limited | Immunotherapeutic methods and systems |
| AUPS148202A0 (en) | 2002-04-02 | 2002-05-09 | Monash University | Immunotherapeutic and immunoprophylactic reagents |
| AU2003228133A1 (en) | 2002-04-22 | 2003-11-03 | Umc Utrecht Holding B.V. | Reduction of unwanted immune reactions |
| GB0210741D0 (en) | 2002-05-10 | 2002-06-19 | Medical Res Council | Methods of therapy |
| GB0308988D0 (en) | 2003-04-17 | 2003-05-28 | Univ Singapore | Molecule |
| DE102004035337A1 (de) * | 2004-07-21 | 2006-03-16 | Merck Patent Gmbh | Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität |
| WO2006075253A2 (en) | 2005-01-11 | 2006-07-20 | Commissariat A L'energie Atomique | Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides. |
| WO2006132607A1 (en) | 2005-06-10 | 2006-12-14 | National University Of Singapore | Mutant allergen(s) |
| DE202005009990U1 (de) * | 2005-06-25 | 2006-11-02 | Hengst Gmbh & Co.Kg | Vorrichtung zum Abscheiden von Ölteilchen aus dem Kurbelgehäuseentlüftungsgas einer Brennkraftmaschine |
| US20070092532A1 (en) | 2005-10-25 | 2007-04-26 | Board Of Trustees Operating Michigan State University | Arthritis vaccines and methods |
| DK2119450T3 (da) | 2005-11-29 | 2013-05-06 | Actogenix Nv | Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener |
| AT503690A1 (de) * | 2006-06-09 | 2007-12-15 | Biomay Ag | Hypoallergene moleküle |
| US20110038881A1 (en) | 2007-05-09 | 2011-02-17 | Circassia Limited | Prognostic assay for determining t cell response to hla antigens and use thereof in field of tissue transplantation |
| GB0710529D0 (en) | 2007-06-01 | 2007-07-11 | Circassia Ltd | Vaccine |
| BRPI0815395A2 (pt) | 2007-08-15 | 2015-02-10 | Circassia Ltd | Composição, vetor, produto, formulação farmacêutica, me´todo in vitro para determinar se as células t reconhecem um polipeptídeo, e, método in vitro para determinar se um indivíduo se encontra ou está em risco de uma condição. |
| EP2042193A1 (en) | 2007-09-28 | 2009-04-01 | Biomay AG | RNA Vaccines |
| US8821887B2 (en) | 2008-08-15 | 2014-09-02 | Circassia Limited | T-cell antigen peptide from allergen for stimulation of IL-10 production |
| SI2393830T1 (sl) * | 2009-02-05 | 2015-04-30 | Circassia Limited | Travni peptidi za cepivo |
-
2010
- 2010-02-05 SI SI201030898T patent/SI2393830T1/sl unknown
- 2010-02-05 SG SG2011055951A patent/SG173523A1/en unknown
- 2010-02-05 WO PCT/GB2010/000198 patent/WO2010089554A1/en not_active Ceased
- 2010-02-05 DK DK10704399T patent/DK2393830T3/en active
- 2010-02-05 AU AU2010212193A patent/AU2010212193B2/en not_active Ceased
- 2010-02-05 PT PT107043994T patent/PT2393830E/pt unknown
- 2010-02-05 GB GB1001954A patent/GB2469894B/en not_active Expired - Fee Related
- 2010-02-05 ES ES10704399.4T patent/ES2532759T3/es active Active
- 2010-02-05 CA CA2751500A patent/CA2751500A1/en not_active Abandoned
- 2010-02-05 MX MX2011008179A patent/MX2011008179A/es active IP Right Grant
- 2010-02-05 NZ NZ594268A patent/NZ594268A/xx not_active IP Right Cessation
- 2010-02-05 HR HRP20150317TT patent/HRP20150317T1/hr unknown
- 2010-02-05 PL PL10704399T patent/PL2393830T3/pl unknown
- 2010-02-05 EP EP10704399.4A patent/EP2393830B8/en not_active Not-in-force
- 2010-02-05 KR KR1020117019157A patent/KR20110111307A/ko not_active Ceased
- 2010-02-05 JP JP2011548765A patent/JP5746053B2/ja not_active Expired - Fee Related
- 2010-02-05 EA EA201171001A patent/EA020792B1/ru not_active IP Right Cessation
- 2010-02-05 EP EP15152164.8A patent/EP2891662A1/en not_active Withdrawn
- 2010-02-05 CN CN201080006665.3A patent/CN102307893B/zh not_active Expired - Fee Related
- 2010-02-05 CN CN201410056647.6A patent/CN103784952B/zh not_active Expired - Fee Related
- 2010-02-05 BR BRPI1008802A patent/BRPI1008802A2/pt not_active IP Right Cessation
- 2010-02-05 US US13/148,024 patent/US8753644B2/en not_active Expired - Fee Related
-
2011
- 2011-07-22 ZA ZA2011/05436A patent/ZA201105436B/en unknown
- 2011-07-24 IL IL214257A patent/IL214257A/en not_active IP Right Cessation
-
2012
- 2012-01-10 HK HK16100075.0A patent/HK1212358A1/en unknown
-
2014
- 2014-05-19 US US14/281,089 patent/US20140302071A1/en not_active Abandoned
-
2015
- 2015-05-07 JP JP2015094636A patent/JP6215252B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2563135T3 (pl) | Kompozycja do kontrolowania chorób roślin i jej zastosowanie | |
| IL248880B (en) | Preparations containing r-g-cysteic acid peptides and their uses for the treatment of eye diseases | |
| PT2771041T (pt) | Composições e suas utilizações na cicatrização óssea | |
| IL230120B (en) | Preparations containing recombinant iduronate-2-sulfatase and their uses | |
| EP2403472A4 (en) | AMPHOLYTIC TERPOLYMERS FOR USE IN PERSONAL CARE COMPOSITIONS | |
| IL218169A (en) | Quinazoline compounds and their pharmaceutical compositions containing them for use in therapy | |
| GB2469894B (en) | Peptides for use in treating allergy to grass pollen | |
| IL232073A0 (en) | Recombinant human naglu protein and its uses | |
| GB2501611B (en) | Alpha-2-macroglobulin compositions and therapeutic uses | |
| ZA201400878B (en) | Plant disease control composition and its use | |
| ZA201106429B (en) | Improvements in and relating to posts | |
| ZA201209705B (en) | Ipmrovements in or relating to ophthalmology | |
| PT2403336E (pt) | Composições de tratamento de plantas e métodos para a sua utilização | |
| ZA201209701B (en) | Improvements in or relating to ophthalmology | |
| ZA201207244B (en) | Plant disease control composition and its use | |
| PL2563140T3 (pl) | Kompozycja do kontrolowania chorób roślin i jej zastosowanie | |
| GB201012903D0 (en) | Improvements in and relating to pharmaceutical compositions | |
| EP2268801A4 (en) | COMPOSITIONS AND METHODS RELATED TO A HUMAN BOCAVIRUS | |
| IL218726A (en) | Pharmaceuticals for the treatment of Down syndrome | |
| IL209220A0 (en) | Plant extract and its therapeutic use | |
| IL221809A (en) | Herbal preparation for the prevention and / or treatment of anxiety and related conditions | |
| GB201011094D0 (en) | Improvements in or relating to ophthalmology | |
| GB201009275D0 (en) | Improvements in or relating to compositions | |
| GB0917454D0 (en) | Improvements in and relating to thermostats | |
| ZA201201369B (en) | Improvements in and relating to cable-barriers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |